PWC News
Monday, August 11, 2025
No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
No Result
View All Result
PWC News
No Result
View All Result

Walgreens Boots Alliance’s Q4 results likely to reflect market challenges | AlphaStreet

Home Markets
Share on FacebookShare on Twitter


Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to take care of gross sales momentum and profitability for fairly a while resulting from a difficult working atmosphere. The primary headwinds to the enterprise are inflation-induced pressure on shopper spending and unfavorable market dynamics. Contemplating these elements, market watchers have issued not-so-optimistic estimates for the August quarter.

The market’s disappointment over Walgreens’ incapacity to remain resilient is seen within the efficiency of its inventory. WBA is without doubt one of the worst-performing shares that continuously underperformed the business and the broad market in latest instances. Final month, the shares slipped into the single-digit territory for the primary time in additional than twenty years. The worth has plunged round 67% to this point this 12 months.

The Deerfield-headquartered retail pharma large is about to publish its fourth-quarter report on Tuesday, October 15, at 7:00 am ET. The consensus earnings estimate for the ultimate three months of fiscal 2024 is $0.36 per share, which is sharply decrease than the $0.67 per share the corporate earned within the prior-year quarter. Gross sales are anticipated to extend modestly to $35.75 billion within the fourth quarter from $35.42 billion a 12 months earlier.

Slowdown

With household budgets coming underneath strain from the financial slowdown, Walgreens’ clients have turn into more and more price-conscious. The state of affairs has compelled the corporate to introduce promotional gives and reductions, which in flip put strain on near-term profitability. In the meantime, the corporate has initiated measures to make its enterprise mannequin sustainable, akin to renegotiating incentives with companions and partnering straight with pharma corporations to reap the benefits of its distinctive place out there.

Walgreens and its friends like CVS Well being have been going through stiff competitors from Amazon ever for the reason that latter entered the pharmacy retail area with the acquisition of PillPack about six years in the past. Whereas persevering with its efforts to spice up retailer visitors, Walgreens has revealed plans to shut practically a fourth of its shops, with a concentrate on unprofitable areas, because the shift to on-line prescriptions continues.

Within the three months ended Might 31, 2024, Walgreens’ gross sales grew throughout all three working segments, driving up the entire to $36.4 billion. Comparable pharmacy gross sales rose 5.7% year-over-year, whereas comparable retail gross sales dropped 2.3%. Excluding particular objects, third-quarter earnings decreased to $0.63 per share from $1.00 per share a 12 months earlier, primarily reflecting decrease sale-leaseback positive aspects and softness in retail and pharmacy efficiency.

Outlook

In the meantime, reported revenue greater than doubled to $344 million or $0.40 per share throughout the three months, aided by a lower in SG&A bills. Earnings missed Road View whereas revenues nearly matched estimates, after beating within the trailing two quarters. In an indication that the pressure on profitability has prolonged into the second half, the Walgreens management forecasts adjusted earnings per share within the $2.80-2.95 vary for fiscal 2024, which is under the prior-year quantity.

“As we sit up for the rest of the 12 months, we’re working underneath the next assumptions. We count on the working atmosphere to stay difficult. We don’t count on an enchancment within the U.S. retail atmosphere. And eventually, we count on script quantity development to stay muted and anticipate continued pressures on pharmacy margins. In gentle of those elements, we’re decreasing our outlook. We now count on to ship adjusted earnings per share of $2.80 to $2.95 for the fiscal 12 months 2024,” stated Walgreens’ CEO Tim Wentworth throughout the Q3 earnings name.

Walgreens’ inventory has been languishing under its 12-month common for round 5 months. After dropping a dismal 54% up to now six months, the shares traded barely larger on Monday afternoon.  



Source link

Tags: AlliancesAlphaStreetBootsChallengesmarketreflectResultsWalgreens
Previous Post

Apple-owned Beats enters Indian market with launch of three products – Details

Next Post

Tim Walz goes on Fox News and attacks Trump’s economic agenda

Related Posts

Activist Carronade spots a hidden gem in Viasat’s business. How the firm may unlock value
Markets

Activist Carronade spots a hidden gem in Viasat’s business. How the firm may unlock value

August 10, 2025
Using my phone as a Paris guidebook cost me  — here’s how to save on your bill when traveling abroad
Markets

Using my phone as a Paris guidebook cost me $50 — here’s how to save on your bill when traveling abroad

August 10, 2025
Opal Fuels targets 2M MMBtu in new construction for 2025 as policy clarity boosts outlook (NASDAQ:OPAL)
Markets

Opal Fuels targets 2M MMBtu in new construction for 2025 as policy clarity boosts outlook (NASDAQ:OPAL)

August 9, 2025
Earnings Preview: What to expect when Deere & Company reports Q3 results | AlphaStreet
Markets

Earnings Preview: What to expect when Deere & Company reports Q3 results | AlphaStreet

August 10, 2025
Amazon’s Small AMD Stock Buy Has Big Implications
Markets

Amazon’s Small AMD Stock Buy Has Big Implications

August 9, 2025
Bank of England chief says no rift with UK government as Revolut licence delay draws scrutiny
Markets

Bank of England chief says no rift with UK government as Revolut licence delay draws scrutiny

August 8, 2025
Next Post
Tim Walz goes on Fox News and attacks Trump’s economic agenda

Tim Walz goes on Fox News and attacks Trump’s economic agenda

2024 NASDAQ 100 Stocks List Spreadsheet | Daily Data Updates

2024 NASDAQ 100 Stocks List Spreadsheet | Daily Data Updates

OSC appoints former Ontario auditor general to lead enforcement effort

OSC appoints former Ontario auditor general to lead enforcement effort

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Bitcoin Remains ‘Undefeatable’, Tether Chief Says
Cryptocurrency

Bitcoin Remains ‘Undefeatable’, Tether Chief Says

by PWC
August 7, 2025
0

Paolo Ardoino, chief govt officer of stablecoin issuer Tether, has known as Bitcoin “undefeatable” in a current X submit. The...

Bank of America Addresses Debanking Claims, Backing Regulatory Reform – Featured Bitcoin News

Bank of America Addresses Debanking Claims, Backing Regulatory Reform – Featured Bitcoin News

August 7, 2025
Activist Carronade spots a hidden gem in Viasat’s business. How the firm may unlock value

Activist Carronade spots a hidden gem in Viasat’s business. How the firm may unlock value

August 10, 2025
We get asked about tariffs all the time. Here’s what we say

We get asked about tariffs all the time. Here’s what we say

August 10, 2025
Resideo Technologies, Inc. 2025 Q2 – Results – Earnings Call Presentation (NYSE:REZI)

Resideo Technologies, Inc. 2025 Q2 – Results – Earnings Call Presentation (NYSE:REZI)

August 6, 2025
Move Over, Tariffs — Power Play Is the New Game in Town | Investing.com

Move Over, Tariffs — Power Play Is the New Game in Town | Investing.com

August 6, 2025
PWC News

Copyright © 2024 PWC.

Your Trusted Source for ESG, Corporate, and Financial Insights

  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact Us

Follow Us

No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis

Copyright © 2024 PWC.